文献速递流行病学与生物统计真实世界研究与卫生经济

美国成人干预性临床试验中英语语言要求的频率:基于ClinicalTrials.gov的系统分析

Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
PubMed 文献 · PLoS Med · 2021-09-14

该研究系统分析2019年1月至2020年12月注册于ClinicalTrials.gov的美国成人干预性试验,发现18.98%要求英语能力,仅2.71%明确提供翻译便利;联邦资助试验的英语要求比例更高(28.86%)。结论认为语言排除影响研究包容性与普适性,应优先翻译材料并取消非科学必要的语言要求。

要点

  • 近两成美国成人干预试验要求英语能力,仅少数明确提供翻译。
  • 联邦资助试验英语要求比例高于产业资助试验。
  • 应消除非科学或伦理上不必要的语言要求以促进包容性。

核心结论

  • 相当比例的美国成人干预性临床试验通过英语语言要求排除了英语能力有限者,影响研究包容性与普适性。

研究设计与样本

  • 利用ClinicalTrials.gov高级检索功能筛选2019年1月1日至2020年12月1日注册的美国成人干预性试验,共纳入14367项符合基线标准的试验。
  • 通过计算机程序检索英语或西班牙语要求,并对有方案文本的试验进行人工阅读确认语言要求。

主要发现

  • 14,367项试验中,18.98%(95% CI 18.34%-19.62%; n=2,727)要求读、说和/或理解英语,2.71%(95% CI 2.45%-2.98%; n=390)明确提及提供其他语言翻译。
  • 联邦资助试验中28.86%(95% CI 27.11%-30.61%; n=746)要求英语能力,4.68%(95% CI 3.87%-5.50%; n=121)明确提供其他语言便利。
  • 产业资助试验中5.30%(95% CI 4.69%-5.90%; n=280)要求英语,0.49%(95% CI 0.30%-0.69%; n=26)提供其他语言便利。
  • 感染性疾病试验要求英语的比例低于所有注册试验(10.07% vs 18.98%; RR=0.53; 95% CI 0.44-0.64; p<0.001),COVID-19试验亦较低(8.18% vs 18.98%; RR=0.43; 95% CI 0.33-0.56; p<0.001)。
  • 有公开方案的试验(n=366)要求英语的比例高于所有注册试验(36.89% vs 18.98%; RR=1.94; 95% CI 1.69-2.23; p<0.001);在抑郁、糖尿病、乳腺癌和前列腺癌四个治疗领域中,抑郁相关试验要求英语的比例最高(52.24%; 95% CI 40.28%-64.20%)。

临床怎么用

  • 申办方、研究者及伦理委员会应优先翻译研究材料,并消除无科学或伦理依据的语言要求,以提升试验包容性与结果普适性。

局限性

  • 计算机程序仅检索「English」和「Spanish」两个词,可能遗漏其他语言便利的证据。
  • 未区分读、说、理解英语及母语为英语的要求,统一归为英语语言要求类别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A number of prior studies have demonstrated that research participants with limited English proficiency in the United States are routinely excluded from clinical trial participation. Systematic exclusion through study eligibility criteria that require trial participants to be able to speak, read, and/or understand English affects access to clinical trials and scientific generalizability. We sought to establish the frequency with which English language proficiency is required and, conversely, when non-English languages are affirmatively accommodated in US interventional clinical trials for adult populations. METHODS AND FINDINGS: We used the advanced search function on ClinicalTrials.gov specifying interventional studies for adults with at least 1 site in the US. In addition, we used these search criteria to find studies with an available posted protocol. A computer program was written to search for evidence of English or Spanish language requirements, or the posted protocol, when available, was manually read for these language requirements. Of the 14,367 clinical trials registered on ClinicalTrials.gov between 1 January 2019 and 1 December 2020 that met baseline search criteria, 18.98% (95% CI 18.34%-19.62%; n = 2,727) required the ability to read, speak, and/or understand English, and 2.71% (95% CI 2.45%-2.98%; n = 390) specifically mentioned accommodation of translation to another language. The remaining trials in this analysis and the following sub-analyses did not mention English language requirements or accommodation of languages other than English. Of 2,585 federally funded clinical trials, 28.86% (95% CI 27.11%-30.61%; n = 746) required English language proficiency and 4.68% (95% CI 3.87%-5.50%; n = 121) specified accommodation of other languages; of the 5,286 industry-funded trials, 5.30% (95% CI 4.69%-5.90%; n = 280) required English and 0.49% (95% CI 0.30%-0.69%; n = 26) accommodated other languages. Trials related to infectious disease were less likely to specify an English requirement than all registered trials (10.07% versus 18.98%; relative risk [RR] = 0.53; 95% CI 0.44-0.64; p < 0.001). Trials related to COVID-19 were also less likely to specify an English requirement than all registered trials (8.18% versus 18.98%; RR = 0.43; 95% CI 0.33-0.56; p < 0.001). Trials with a posted protocol (n = 366) were more likely than all registered clinical trials to specify an English requirement (36.89% versus 18.98%; RR = 1.94, 95% CI 1.69-2.23; p < 0.001). A separate analysis of studies with posted protocols in 4 therapeutic areas (depression, diabetes, breast cancer, and prostate cancer) demonstrated that clinical trials related to depression were the most likely to require English (52.24%; 95% CI 40.28%-64.20%). One limitation of this study is that the computer program only searched for the terms "English" and "Spanish" and may have missed evidence of other language accommodations. Another limitation is that we did not differentiate between requirements to read English, speak English, understand English, and be a native English speaker; we grouped these requirements together in the category of English language requirements. CONCLUSIONS: A meaningful percentage of US interventional clinical trials for adults exclude individuals who cannot read, speak, and/or understand English, or are not native English speakers. To advance more inclusive and generalizable research, funders, sponsors, institutions, investigators, institutional review boards, and others should prioritize translating study materials and eliminate language requirements unless justified either scientifically or ethically.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Muthukumar AV, Morrell W, Bierer BE, et al. Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov. PLoS Med. 2021. PMID: 34520467. doi:10.1371/journal.pmed.1003758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。